Related content

Regulation of the alternative pathway on injured cells by factor H, FHL-1 and C-reactive protein

By Jarva H.   Hellwage J.   Meri S.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 69-69

Elsevier

Access to resources Recommend Favorite

Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 182-190

Bentham Science Publishers

Access to resources Recommend Favorite

The Host Complement System and Arbovirus Pathogenesis

By  

Current Drug Targets, Vol. 9, Iss. 2, 2008-01 ,pp. : 165-172

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the APP Non-Amyloidogenic Signaling Pathway and Targeting -Secretase as an Alternative Drug Target for Treatment of Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 14, Iss. 27, 2007-11 ,pp. : 2848-2864

Bentham Science Publishers

Access to resources Recommend Favorite

Does Calprotectin Represent a Regulatory Factor in Host Defense or a Drug Target in Inflammatory Disease?

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 7, Iss. 1, 2007-03 ,pp. : 1-5

Bentham Science Publishers

Access to resources Recommend Favorite